Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region

Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan

Clin Mol Hepatol. 2023;29(2):277-292. Published online January 30, 2023

DOI: https://doi.org/10.3350/cmh.2022.0212

View: 8374 Download: 576 Web of Science: 35 Crossref: 38

Novel biomarkers for the management of chronic hepatitis B

Takako Inoue, Yasuhito Tanaka

Clin Mol Hepatol. 2020;26(3):261-279. Published online June 15, 2020

DOI: https://doi.org/10.3350/cmh.2020.0032

View: 16142 Download: 716 Web of Science: 83 Crossref: 87

Original Article

Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis

Yejoo Jeon, Eun Sun Jang, Yun Suk Choi, Jin-Wook Kim, Sook-Hyang Jeong

Clin Mol Hepatol. 2016;22(3):359-365. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0033

View: 12789 Download: 147 Web of Science: 23 Crossref: 22

Case Report

Intrahepatic bile duct adenoma in a patient with chronic hepatitis B accompanied by elevation of alpha-fetoprotein

Jem Ma Ahn, Yong-Han Paik, Jun Hee Lee, Ju Yeon Cho, Won Sohn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Byung Chul Yoo

Clin Mol Hepatol. 2015;21(4):393-397. Published online December 24, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.4.393

View: 9010 Download: 79 Web of Science: 3 Crossref: 1

Original Article

The retrospective cohort study for survival rate in patients with advanced hepatocellular carcinoma receiving radiotherapy or palliative care

Hyuk Soo Eun, Min Jung Kim, Hye Jin Kim, Kwang Hun Ko, Hee Seok Moon, Eaum Seok Lee, Seok Hyun Kim, Heon Young Lee, Byung Seok Lee

Clin Mol Hepatol. 2011;17(3):189-198. Published online September 30, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.3.189

View: 7643 Download: 71 Crossref: 6

3

Could patients who underwent hepatic resection due to hepatocellular carcinoma with high alpha-fetoprotein be monitored for recurrence by alpha-fetoprotein Level?

Woo Young Shin, M.D., Kyung-Suk Suh, M.D. Taehoon Kim, M.D. Young Min Jeon, M.D. Nam-Joon Yi, M.D. Kuhn Uk Lee, M.D.

Clin Mol Hepatol. 2010;16(2):168-175. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.168

View: 4703 Download: 22 Crossref: 3

4

A case of Liver metastasis of gastric hepatoid adenocarcinoma

Eun Hyoung Jeong, M.D., Dong Hyun Kim, M.D., Sung Ho Ma, M.D., Eui Jong Chung, M.D., Sang Su Bae, M.D., A Young Park, M.D. Hyung Jun Chu, M.D.

Clin Mol Hepatol. 2009;15(2):201-208. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.201

View: 5023 Download: 49 Crossref: 2

Liver Metastasis of Colon Cancer with a High Serum alpha-Fetoprotein Level: Report of a Case

Min An, M.D., Jeong A Shin, M.D., Sang-Min Lee, M.D., Tak Yoon, M.D. Weon Seo Park, M.D. Joon Il Choi, M.D., and Chang-Min Kim, M.D.

Clin Mol Hepatol. 2006;12(4):562-567. Published online January 1, 1970

View: 2913 Download: 31

3

Optimal Cut-off Value of PIVKA-II for Diagnosis of Hepatocellular Carcinoma - Using ROC Curve -

Myong Jin Kim , Kang Woo Bae , Pyoung Ju Seo , In Kook Jeong , Jung Hyuk Kim , Bo Han Lee , Ki Tae Bang , Dong Woo Kim , Il Han Song

Clin Mol Hepatol. 2006;12(3):404-411. Published online January 1, 2000

View: 3862 Download: 74

1

PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Sook-Hyang Jeong

Clin Mol Hepatol. 2006;12(3):315-317. Published online January 1, 2000

View: 2704 Download: 23

3

Clinical Features of Hepatocellular Carcinoma with Reference to Serum Alpha-fetoprotein Levels in Korean Patients

Jong Cheol Kim, M.D., Soong Hwan Lee, M.D., Byung Joo Roh, M.D. Sung Woo Kim, M.D., Sung Soo Park, M.D. and Dong Hoo Lee, M.D.*

Clin Mol Hepatol. 1999;5(4):322-331. Published online January 1, 2000

View: 2687 Download: 14

1 |

Viewed By 5265	MAFLD: How is it different from NAFLD?
Viewed By 5086	Examining the therapeutic landscape of beta-blockers in portal hypertension
Viewed By 4609	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4599	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4453	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma

Cited By 248	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 204	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 145	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 138	MAFLD: How is it different from NAFLD?
Cited By 114	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search